Navigation Links
Cardium Reports On NYSE MKT Noncompliance Notice And Compliance Plan
Date:12/6/2012

SAN DIEGO, Dec. 6, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) reported on a communication from staff of its current listing exchange that it considered the company to be noncompliant with certain listing requirements based on its quarterly report for the period ended September 30, 2012, and provided that the company should submit a plan to staff of the exchange that would reestablish compliance with the NYSE MKT listing requirement by March 31, 2013. The company reported that it has already submitted a plan designed to reestablish compliance with the exchange's requirement in advance of the March 31, 2013 timeframe.  Additional information and provisions regarding the NYSE MKT requirements are found in Part 10 of its company guide.

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

Based on the company's quarterly report on Form 10-Q for the period ended September 30, 2012, noncompliance was noted with respect to the requirement of section 1003(a)(iv) of the company guide for NYSE MKT. The exchange indicated that in order to maintain its NYSE MKT listing, a plan should be submitted by December 31, 2012 addressing regaining compliance with Section 1003(a)(iv) of the exchange's company guide by March 31, 2013. Additional information and provisions regarding the NYSE MKT requirements are found in Part 10 of its company guide.  The company has disputed the staff's basis for its determination of deemed noncompliance, but it has also already submitted a plan designed to reestablish compliance with the listing requirement in advance of the timeline requested.

The communication and compliance plan has no current effect on the listing of the company's shares on the exchange.  If the plan is not acceptable or the company does not make sufficient progress under the plan or reestablish compliance by March 31, 2013, then staff of the exchange ma
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cardium to Present at Upcoming Investor Conferences
2. Cardium Presents First Quarter 2012 Financial Results and Recent Developments
3. Published Findings In Human Gene Therapy Methods Journal Demonstrate Cardiums New Catheter-Based Method Significantly Boosts Gene Delivery To The Heart
4. Cardium Announces Patent Award For Rights To Cardiovascular Gene Therapy For The Treatment Of Heart Disease
5. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
6. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
7. Interleukin Genetics Reports Third Quarter 2011 Financial Results
8. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
9. Nile Therapeutics Reports 2011 Third Quarter Financial Results
10. Pharmasset Reports Fiscal Year End 2011 Financial Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 Flagship Biosciences LLC, ... services to the pharmaceutical and medical device industries, has ... The fast growing company has consolidated its histology and ... Boulder to Westminster, CO, just north of Denver. ... 7575 W. 103rd Ave., Suite 100, Westminster, CO 80021 ...
(Date:8/27/2014)... 2014  ARCH Venture Partners, one of the ... development of seed and early-stage advanced technology companies, ... with more than $400 million in subscriptions. ARCH ... target by more than $150 million. ... and potential of our approach to finding and ...
(Date:8/27/2014)... FL (PRWEB) August 27, 2014 BIOEQUA, ... applied through the use of a handheld spray, has ... the United States. , The brand began with ... BIOEQUA researchers were surprised to learn that the application ... made extremely small and delivered directly to skin's basal ...
(Date:8/27/2014)... Remcom announces an update to XFdtd® ... the biomedical industry. The central biomedical addition in ... to the Bio-Pro version of the software. XFdtd ... calculate the biological effects of electromagnetic fields. In ... versions to expand engineers’ post-processing options. , The Biological ...
Breaking Biology Technology:Flagship Biosciences Announces Relocation and Expansion 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... great thing about the tech arena: even when the economy ... them turn into start-up ventures (whether self-funded, friends-and-family backed or ... they tend to create jobs. They create lots of jobs. ... companies. , ,The trend shows no sign of slowing. , ...
... into two major groups: open minds in closed societies and ... of products must address the issues of sexual connotation with ... UK went soft and packed up their most cherished and ... all over the world are happy as they seriously objected ...
... nanotechnology exhibit to open Thursday , Madison, Wis. ... an exhibit on advances in nanotechnology, run by the university ... 4:30 p.m. on December 16 during a campus open house, ... in science fiction as the manufacture of tiny robots, has ...
Cached Biology Technology:How to duck the 3 most common entrepreneurial hiring traps 2How to duck the 3 most common entrepreneurial hiring traps 3How to duck the 3 most common entrepreneurial hiring traps 4We are American No sex, please 2We are American No sex, please 3We are American No sex, please 4Tech Digest: Nanotechnology, GE Healthcare, NovaMed, PhysioGenix 2
(Date:8/27/2014)... based upon a proxy for impact have been identified ... approach to scientific research. , The researchers from the ... top 100 pathogens affecting humans and the top 100 ... will help governments across the continent plan for risks ... a result of climate change, and for biosecurity. , ...
(Date:8/27/2014)... German . , ... disease affecting the peripheral nervous system. Researchers from the ... Experimental Medicine and University Medical Centre Gttingen have discovered ... rats with the disease. These cells enwrap the nerve ... facilitates the rapid transfer of electrical impulses. If Schwann ...
(Date:8/27/2014)... (June, 2014) Outstanding basic research, a growing ... dedication to patient care have earned the Herbert ... Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 ... National Cancer Institute (NCI). The grant renews the ... Comprehensive Cancer Centers in New York City and ...
Breaking Biology News(10 mins):Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Potential therapy for incurable Charcot-Marie-Tooth disease 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 2Herbert Irving Comprehensive Cancer Center awarded $18 million grant 3Herbert Irving Comprehensive Cancer Center awarded $18 million grant 4
... Children,s Research Hospital have gained new insights into regulation ... As the cell,s molecular overachievers, calpains function ... in tissues, the death of damaged cells, insulin secretion, ... this broad set of responsibilities is that defective or ...
... latest American Chemical Society (ACS) News Service Weekly PressPac with ... Engineering News .,Please credit the individual journal or the American ... CONTENT IS FOR IMMEDIATE RELEASE EXCEPT ARTICLE #5, which is ... ARTICLE #1 FOR IMMEDIATE RELEASE Microcapsules ...
... on the hunt for a better way to clean up ... them watch molecules break down on the surface of a ... "We can see the vibrations of the bonds between the ... the way these vibrations change frequency and intensity with time, ...
Cached Biology News:New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3
Mouse monoclonal [ICRF 44] to Integrin alpha M...
CKB Antibody (N-term) Antigen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected within aa 1~100 of human CKB. Molecular Weight: 42644 Da...
384 Cluster Tube Racks...
Leptin Receptor Polyclonal Ab 100 ug purified rabbit anti-mouse Leptin Receptor. Tested in Western blotting....
Biology Products: